Rapporti settoriali Mar 08, 2022 Pakistan: medtech e mercato della salute digitale Con una popolazione di circa 220 milioni di abitanti, il Pakistan presenta un mercato della salute in crescita grazie alla rapida urbanizzazione,...
Comunicati Stampa Mar 10, 2022 Switzerland Global Enterprise e Svizzera Turismo invitano aziende innovative in Svizzera La Svizzera, nel suo ruolo di piazza d’innovazione, è ideale per lo sviluppo di nuovi modelli di business con tecnologie del futuro. Un ruolo imp...
News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News Mar 10, 2021 Researchers from Bern developed an approach to predict cancer therapy success Scientists from the University and Inselspital of Bern have established organoid culture models from prostate tumor biopsies. These are small clu...
Actualités Jan 26, 2023 Les Hôpitaux Universitaires de Genève lancent le Centre de Médecine Virtuelle Les Hôpitaux Universitaires de Genève (HUG) ont lancé le Centre de médecine virtuelle (CMV), un centre pionnier pour l'intégration des nouvelles ...
News Jan 27, 2021 Basel researchers developing universal cancer therapy Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to treat any form of cancer imm...
News Mar 08, 2021 The Lausanne University Hospital still ranks among the ten best hospitals worldwide in 2021 After an especially challenging year 2020 for hospitals, the prestigious U.S. magazine Newsweek has once again included the Lausanne University H...
Actualités Apr 26, 2023 Le secteur biotechnologique suisse prospère malgré les défis mondiaux L’industrie biotechnologique de la Suisse occidentale continue de prospérer, faisant preuve de résilience face aux défis mondiaux. L’écosystème u...
News Feb 09, 2021 Biopôle to welcome three new buildings dedicated to life sciences by 2024 Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and labora...
Actualités Feb 13, 2023 L’Hôpital de La Tour va créer un campus de la santé à Genève L’établissement privé de soins de santé Hôpital de la Tour a conclu un accord de CHF 750 millions pour créer un grand projet de campus de santé a...
News Mar 30, 2020 A new application to manage COVID-19 infectious samples “made in Bern” The Institute for Infectious Diseases of the University of Bern and the University Emergency Center of the University Hospital of Bern have joint...
Guida Sep 23, 2021 Farsi strada nel panorama del sistema sanitario del Regno Unito Volete conoscere meglio il sistema sanitario del Regno Unito? È un dato di fatto che l’innovazione digitale possa rivoluzionare il modo in cui pr...
News Oct 07, 2020 Diabetes specialist Ypsomed develops world’s first zero carbon emission autoinjector Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The new YpsoMate Zero uses alternative biopolymers and a nov...
Success stories Apr 21, 2021 “Tutte le componenti della catena del valore si trovano qui, dalla ricerca e sviluppo alla produzione e alla commercializzazione.” La Svizzera è un hub importante per il settore delle scienze della vita. È il secondo maggiore esportatore al mondo di medicinali confezionati e ...
Aktuell Feb 01, 2022 Medbase, Hirslanden und Partner lancieren Gesundheitsportal Hirslanden und Medbase gleisen gemeinsam mit zwei weiteren Partnern aus der Greater Zurich Area und der Groupe Mutuel ein digital unterstütztes G...
Actualités Feb 28, 2023 Terapet lève CHF 2,3 millions pour sa technologie innovante de traitement du cancer La société medtech genevoise Terapet a annoncé la clôture de son premier tour de table de pré-série A pour un montant de CHF 2,3 millions.
News May 05, 2020 Fribourg institutions launch a smell test to detect Covid-19 Researchers from the SICHH and the University of Fribourg are conducting a study to determine whether loss of taste and smell is a reliable bioma...